GENE ONLINE|News &
Opinion
Blog

Innovation
Technology CRISPR
CRISPR Scientists Receive 2020 Wolf Prize in Medicine
2020-01-15
Manufacturing
The 38th Annual J.P. Morgan Healthcare Conference – What to Expect?
2020-01-13
Technology Cancer
Single-cell genomic analysis (SCG)—A Key to Decipher the Cancer Landscape
2020-01-04
Technology
‘CRISPR Babies’ Researchers Given Prison Sentence by Chinese Court
2019-12-30
In-Depth Archeology
The entire human genome decoded from a thousand year-old “chewing gum”
2019-12-30
Technology
RNA Therapeutics: An Overview
2019-12-25
Trials & Approvals Neurodegenerative Disease
Biogen’s BIIB059 May End a 10-Year Drought with New Lupus Drug
2019-12-18
Interviews Bioinspiration
Jeffrey Karp: Innovating Modern Healthcare Through Bioinspiration
2019-12-18
Trials & Approvals Cancer
FoundationOne®CDx Approved as Companion Diagnostic for Novartis’ Piqray
2019-12-09
Technology Cas9
Broad Institute and Cyrus Biotech Join Hands to Develop Safe CRISPR
2019-12-05
R&D Clostridium
Combating Clostridium difficile infections using Fecal Microbiota Transplant
2019-12-02
R&D Aging
Regenerative Medicine provides Answer to Aging: ICare Global Health Biotech’s SRF Technology Aims to Treat Arthritis in the Elderly
2019-12-02
Technology
Prime Editing: A New Twist in the CRISPR Tale
2019-11-28
R&D GalNAC
Novo Nordisk Becomes Dicerna’s Fifth Big Pharma Partnership
2019-11-19
In-Depth Depression
SECUADO – The Hope to Enhance Schizophrenia Patients’ Quality of Life
2019-11-14
1 … 51 52 53 54 55 … 58
LATEST
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top